SecBot SecBot
Insider Cluster (4 insiders) ·Filed Aug 11, 2026

DNTH

Dianthus Therapeutics, Inc. /DE/
NEUTRAL
Impact 4/10
Horizonimmediate Processed3mo ago
Insider cluster: 4 insiders, $3.1M total
Actionable Insight • Neutral

This cluster is routine, all sales follow option vesting/exercise events and are immaterial by dollar size. No bearish read-through. Monitor next earnings (likely catalyst) or any material clinical update given the biotech sector context. The 95% analyst bullish consensus remains unchanged.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$112.41
T+0 close · Aug 11, 2026 · via day close
Latest settled
−26.15%
T+60 · $83.01
Vs SPY
−21.04%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 12 $112.41entry
  2. T+1 · 3mo ago −2.50%α −3.20% · $109.60
  3. T+5 · 3mo ago +1.15%α +1.59% · $113.70
  4. T+20 · 2mo ago −8.12%α −6.22% · $103.28
  5. T+60 · 12d ago −26.15%α −21.04% · $83.01
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Multiple Dianthus Therapeutics insiders, including CEO Marino and GC Veness, executed open-market sales totaling $3.15M over a 7-day window, with $1.12M (CEO) and $1.78M (GC) concentrated on a single day. The sales are likely liquidity-driven following vesting and option exercises (non-cash derivatives), but the CEO's involvement and total value relative to the $6.5B market cap (0.048%) suggests routine portfolio diversification rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$3.1M
Insiders
4

Key Facts

  • 4 insiders sold a total of ~$3.15M in open-market transactions from Aug 7-10, 2026.
  • CEO Marino sold 10.4K shares at $107.49 for $1.12M on Aug 7.
  • GC Veness sold 16.2K shares at $110.38 for $1.78M on Aug 10.
  • Total insider sales represent 0.048% of $6.5B market cap, well below any material threshold.
  • All sales coincided with option exercises (non-cash derivative exercise events on the same dates).

Financial Impact

Total insider sales of $3.15M represent less than 0.05% of market cap, economically insignificant.

dilution

Risk Factors

  • No open-market buys from any insider to counterbalance selling.
  • If stock declines >10%, the lack of insider buying could amplify selling pressure.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DNTH-1786775156334

Track record

23 reports on DNTH

Performance horizon

7 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +41.40% at T+60 after the Jun 11, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $89.76 Now $89.55 −0.23% settles Nov 17
  2. Nov 9, 20267d ago 144 Neutral 3/10 Entry $88.81 to $89.30 Now $89.55 +0.83% ▲ +0.55% −0.77% vs SPY
  3. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  4. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $83.01 to $86.03 Now $89.55 +7.88% ▲ +3.64% +3.33% vs SPY
  5. Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
  6. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
  7. Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $81.57 to $77.58 Now $89.55 +9.78% ▼ −4.89% −4.88% vs SPY
  8. Aug 11, 202613w ago Insider Cluster Neutral 4/10 Viewing Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
  9. Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
  10. Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (11h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 15, 2026